These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 27210522)
1. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives. Bakr RB; Azouz AA; Abdellatif KR J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drug approach: Synthesis and biological evaluation of novel pyrazolo[3,4-d]pyrimidine compounds. Atatreh N; Youssef AM; Ghattas MA; Al Sorkhy M; Alrawashdeh S; Al-Harbi KB; El-Ashmawy IM; Almundarij TI; Abdelghani AA; Abd-El-Aziz AS Bioorg Chem; 2019 May; 86():393-400. PubMed ID: 30763886 [TBL] [Abstract][Full Text] [Related]
5. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives. Abdellatif KR; Fadaly WA; Ali WA; Kamel GM J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738 [TBL] [Abstract][Full Text] [Related]
7. Novel pyrimidine-pyridine hybrids: Synthesis, cyclooxygenase inhibition, anti-inflammatory activity and ulcerogenic liability. Abdelgawad MA; Bakr RB; Azouz AA Bioorg Chem; 2018 Apr; 77():339-348. PubMed ID: 29421710 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore. Abdellatif KR; Fadaly WA Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776 [TBL] [Abstract][Full Text] [Related]
9. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold. Bakr RB; Ghoneim AA; Azouz AA Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of derivatives of 2-{2-fluoro-4-[(2-oxocyclopentyl)methyl]phenyl}propanoic acid: nonsteroidal anti-inflammatory drugs with low gastric ulcerogenic activity. Yamakawa N; Suemasu S; Okamoto Y; Tanaka K; Ishihara T; Asano T; Miyata K; Otsuka M; Mizushima T J Med Chem; 2012 Jun; 55(11):5143-50. PubMed ID: 22404396 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208 [TBL] [Abstract][Full Text] [Related]
12. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile. Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-inflammatory screening, molecular docking, and COX-1,2/-5-LOX inhibition profile of some novel quinoline derivatives. Chaaban I; Rizk OH; Ibrahim TM; Henen SS; El-Khawass EM; Bayad AE; El-Ashmawy IM; Nematalla HA Bioorg Chem; 2018 Aug; 78():220-235. PubMed ID: 29602046 [TBL] [Abstract][Full Text] [Related]
14. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]